NON-MELANOMA SKIN CANCER (NMSC)

Clinical trials for NON-MELANOMA SKIN CANCER (NMSC) explained in plain language.

Never miss a new study

Get alerted when new NON-MELANOMA SKIN CANCER (NMSC) trials appear

Sign up with your email to follow new studies for NON-MELANOMA SKIN CANCER (NMSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Could existing melanoma drugs work for other rare cancers? new trial aims to find out.

Disease control Not yet recruiting

This trial tests two approved drugs, dabrafenib and trametinib, in people with rare cancers that have a BRAF V600 mutation. The drugs are already used for melanoma and lung cancer. About 30 adults, children, and teens will take part. The goal is to see if the drugs shrink tumors …

Matched conditions: NON-MELANOMA SKIN CANCER (NMSC)

Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control

Last updated May 15, 2026 11:57 UTC

NON-MELANOMA SKIN CANCER (NMSC)

Get alerted when new NON-MELANOMA SKIN CANCER (NMSC) trials appear

Could existing melanoma drugs work for other rare cancers? new trial aims to find out.